Skip to main content
Right Decision Service: supporting decisions for Scotland's health and care
Right Decisions
All resources
Organisations
Topics
Learning & support
How to deliver RDS tools
Feedback
Menu
Search
Search for toolkits, guidelines and other information:
Search
Right Decisions
Shared content
GGC - Mental Health
Back
MyPsych
Mental Health Medicines Guidance
Mental Health Medicines Guidance
MyPsych
Acute management of people who use drugs (MHS MRG 11)
Administration & Supply of medicines using a PGD SOP (MHS MRG 47)
Alcohol withdrawal - in patient management protocol (MHS MRG 27)
Antidepressants - stopping & switching (MHS MRG 32)
Antipsychotics - combination and augmentation guidance (MHS MRG 16)
Antipsychotics - depot long-acting injection prescribing algorithm (MHS MRG 05)
Antipsychotics - effective use of first generation depot injections (MHS MRG 04)
Attention Deficit and Hyperactivity Disorder- treatment (MHS MRG 54)
Benzatropine - protocol for unlicensed use (MHS MRG 18)
Clarithromycin & QTc prolongation alert
Clozapine - 15 day titration regime BLANK (MHS MRG 03.03.02)
Clozapine - 15 day titration regime STANDARD (MHS MRG 03.03.01)
Clozapine - developing a treatment plan for managing off licence use (MHS MRG 03.04)
Clozapine - options for initiation (MHS MRG 03.03)
Clozapine - out patient prescription form (MHS MRG 03.05)
Clozapine - patient holiday supplies (MHS MRG 03.10)
Clozapine - patient information standards (MHS MRG 03.09)
Clozapine - planned withdrawal (MHS MRG 3.12)
Clozapine - plasma monitoring guidance (MHS MRG 03.07)
Clozapine - protocol for rechallenge following a neutropenic episode (MHS MRG 03.11)
Clozapine - protocol for the use of clozapine liquid (MHS MRG 03.06)
Clozapine - protocol for use of oro-dispersible tablets (MHS MRG 3.15)
Clozapine - re-titration following a treatment break (MHS MRG 3.14)
Clozapine- safe use in an aging population (MHS MRG 3.16)
Clozapine - service standards (MHS MRG 03.01)
Clozapine induced constipation - assessment and treatment (MHS MRG 03.08)
Cognitive enhancers- physical health monitoring (MHS MRG 44)
Controlled drugs - advice for checking stock (MHS MRG 10)
Controlled Drug Prescription Requirements (MHS MRG 55)
Covert medication and dysphagia - safe and cost effective administration (MHS MRG 02)
Desirable drug- procedure for ordering and reconciling (MHS MRG 38)
Difficult-to-treat depression pathway (MHS MRG 49)
Emergency cupboard list and procedure for out of hours access (MHS MRG 12)
Extended passes- protocol for managing medication (MHS MRG 50)
Extrapyramidal side effects- Management (MHS MRG 43)
Fluphenazine decanoate - protocol for unlicensed use (MHS MRG 35)
Glasgow Antipsychotic Side-effect Scale (GASS)
Haloperidol and QTc interval prolongation (MHS MRG 07)
In-patient controlled drug administration SOP (MHS MRG 39)
In-patient medication administration SOP (MHS MRG 40)
Insulin - safer use (MHS MRG 21)
Lithium - good practice standards (MHS MRG 26)
Lithium bundle (MHS MRG 24)
Lithium- community bundle (MHS MRG 45)
Lithium- patient information standards (MHS MRG 34)
Medication given out with prescribed times - administration and recording (MHS MRG 15)
Neuroleptic malignant syndrome (MHS MRG 31)
Non-formulary and unlicensed medicines - advice on access (MHS MRG 08)
Non-formulary request form (MHS MRG 08.01)
Nurse dispensing outwith pharmacy hours (MHS MRG 14)
Off-label unlicensed prescribing guidance in MHS (MHS MRG 25)
Olanzapine- guidance for the use of olanzapine embonate LAI (MHS MRG 37)
Opioids - safer use (MHS MRG 22)
Paracetamol overdose guidance (MHS MRG 17)
Patient Group Directive- Diazepam (MHS MRG 51)
Patient Group Directive- Promethazine (MHS MRG 52)
Patient Group Directive- Zopiclone (MHS MRG 53)
Pirenzepine - protocol for unlicensed use (MHS MRG 19)
Prescribing as required psychotropic drugs (MHS MRG 28)
Primary care psychotropic good practice guidance (MHS MRG 46)
Procedure for Ordering and Reconciling PGDs (MHS MRG 48)
Response ward emergency tray locations (MHS MRG 13)
Safe secure handling of medicines in hospital wards (MHS MRG 01)
Serotonin syndrome (MHS MRG 30)
Thioridazine - protocol for unlicensed use (MHS MRG 20)
Use of a second staff member 'runners' to deliver medication to the patient
Use of multi-dose compliance aids- good practice statement (MHS MRG 36)
Valproate- use within Mental Health Services (MHS MRG 41)
Self medication programme guidance (MHS MRG 56)
Back to the top